Ophthalmology
Volume 112, Issue 3 , Pages 386-390 , March 2005

Risk of glaucoma in ocular hypertension with and without pseudoexfoliation

  • Kirsti Grødum, MD, PhD

      Affiliations

    • Corresponding Author InformationCorrespondence and reprint requests to Kirsti Grødum, MD, PhD, Department of Ophthalmology, Malmö University Hospital, S-20502 Malmö, Sweden
  • ,
  • Anders Heijl, MD, PhD
  • ,
  • Bo Bengtsson, MD, PhD

Received 7 April 2004 ,Accepted 14 September 2004.

References 

  1. Kass MA , Heuer DK , Higginbotham EJ , et al. Ocular Hypertension Treatment Study Group   The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma . Arch Ophthalmol . 2002;120:701–713
  2. Linnér E . Ocular hypertension: the clinical course during ten years without therapy (Aqueous humour dynamics) . Acta Ophthalmol (Copenh) . 1976;54:707–720
  3. Kitazawa Y , Horie T , Aoki S , et al.  Untreated ocular hypertension (A long-term prospective study) . Arch Ophthalmol . 1977;95:1180–1184
  4. Lundberg L , Wettrell K , Linnér E . Ocular hypertension: a prospective twenty-year follow-up study . Acta Ophthalmol (Copenh) . 1987;65:705–708
  5. Schulzer M , Drance SM , Douglas GR . A comparison of treated and untreated glaucoma suspects . Ophthalmology . 1991;98:301–307
  6. Schuman JSAntiglaucoma medications: a review of safety and tolerability issues related to their use . Clin Ther . 2000;22:167–208
  7. Diggory P , Franks W . Medical treatment of glaucoma—a reappraisal of the risks . Br J Ophthalmol . 1996;80:85–89
  8. Robin AL , Frick KD , Katz J , et al.  The Ocular Hypertension Treatment Study. Intraocular pressure lowering prevents the development of glaucoma, but does that mean we should treat before the onset of disease? . Arch Ophthalmol . 2004;122:376–378
  9. Jampel HD . We should treat fewer patients with elevated introcular pressure now that we know the results of the Ocular Hypertension Treatment Study . Arch Ophthalmol . 2004;122:378–379
  10. Gordon MO , Beiser JA , Brandt JD , et al. Ocular Hypertension Treatment Study Group   The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma . Arch Ophthalmol . 2002;120:714–720
  11. Ritch R . Exfoliation syndrome: more than meets the eye . Acta Ophthalmol Scand . 2002;80:465–467
  12. Heijl A , Leske MC , Bengtsson B , et al. Early Manifest Glaucoma Trial Group   Reduction of intraocular pressure and glaucoma progression (Results from the Early Manifest Glaucoma Trial) . Arch Ophthalmol . 2002;120:1268–1278
  13. Aasved H . Intraocular pressure in eyes with an without fibrillopathia epitheliocapsularis (so-called senile exfoliation or pseudoexfoliation) . Acta Ophthalmol (Copenh) . 1971;49:601–610
  14. Ringvold A , Blika S , Elsås J , et al.  The middle-Norway Eye-Screening Study (II. Prevalence of simple and capsular glaucoma) . Acta Ophthalmol (Copenh) . 1991;69:273–280
  15. Mitchell P , Wang JJ , Hourihan F . The relationship between glaucoma and pseudoexfoliation: the Blue Mountains Eye Study . Arch Ophthalmol . 1999;117:1319–1324
  16. Davanger M , Ringvold A , Blika S . Pseudo-exfoliation, IOP and glaucoma . Acta Ophthalmol (Copenh) . 1991;69:569–573
  17. Ekström C . Elevated intraocular pressure and pseudoexfoliation of the lens capsule as risk factors for chronic open-angle glaucoma: a population-based five-year follow-up study . Acta Ophthalmol (Copenh) . 1993;71:189–195
  18. Høvding G , Aasved H . Prognostic factors in the development of manifest open angle glaucoma: a long-term follow-up study of hypertensive and normotensive eyes . Acta Ophthalmol (Copenh) . 1986;64:601–608
  19. Pohjanpelto P . Influence of exfoliation syndrome on prognosis in ocular hypertension ≥ (greater than or equal to) 25 mm. A long term follow-up . Acta Ophthalmol (Copenh) . 1986;64:39–44
  20. Brooks AM , Gillies WE . The presentation and prognosis of glaucoma in pseudoexfoliation of the lens capsule . Ophthalmology . 1988;95:271–276
  21. Åsman P , Heijl A . Evaluation of methods for automated hemifield analysis in perimetry . Arch Ophthalmol . 1992;110:820–826
  22. Åsman P , Heijl A . Glaucoma Hemifield Test: automated visual field evaluation . Arch Ophthalmol . 1992;110:812–819
  23. Leske C , Heijl A , Hyman L , Bengtsson B  Early Manifest Glaucoma Trial Group . Early Manifest Glaucoma Trial: design and baseline data . Ophthalmology . 1999;106:2144–2153
  24. Epstein DL , Krug JH , Hertzmark E , et al.  A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects . Ophthalmology . 1989;96:1460–1467
  25. Kass MA , Gordon MO , Hoff MR , et al.  Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial . Arch Ophthalmol . 1989;107:1590–1598
  26. Ritch R . Exfoliation syndrome: the most common identifiable cause of open-angle glaucoma . J Glaucoma . 1994;3:176–178
  27. Netland PA , Ye H , Streeten BW , Hernandez MR . Elastosis of the lamina cribrosa in pseudoexfoliation syndrome with glaucoma . Ophthalmology . 1995;102:878–886
  28. Schlötzer-Schrehardt U , Kuchle M , Naumann GO . Electron-microscopic identification of pseudoexfoliation material in extrabulbar tissue . Arch Ophthalmol . 1991;109:565–570
  29. Cursiefen C , Händel A , Schönherr U , Naumann GOH . Das Pseudoexfoliationssyndrom bei Patienten mit retinaler Venenast- und Zentralvenenthrombose . Klin Monatsbl Augenheilkd . 1997;211:17–21
  30. Leske MC , Heijl A , Hussein M , et al. Early Manifest Glaucoma Trial Group   Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial . Arch Ophthalmol . 2003;121:48–56

 Manuscript no. 240265.

 This study was supported by the Swedish Research Council (grant no.: K2002-74X-10426-10A), Malmö University Hospital, and the Järnhardt Foundation.

 The authors have no proprietary or financial interest in any of the material in this article.

PII: S0161-6420(04)01522-2

doi: 10.1016/j.ophtha.2004.09.024

Ophthalmology
Volume 112, Issue 3 , Pages 386-390 , March 2005